Mary Kay Inspires Beauty Trends at Spring/Summer 2020 Fashion Weeks in Europe
20.12.2019 02:06:00 EET | Business Wire | Press release
Mary Kay Inc. continues to make its mark on the beauty industry through its ongoing partnerships with Ukrainian and Belarus Fashion Weeks, Mercedes-Benz Fashion Week Russia, and Bratislava Fashion Days in Slovakia and Czech Republic.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191219005838/en/
Mercedes-Benz Fashion Week Russia (Photo: Mary Kay Inc.)
“As an innovator of beauty trends, Mary Kay along with beauty artists, unveiled 2020 runway looks throughout fashion weeks in Europe,” stated Tara Eustace, President of Mary Kay for the European Region. “The runways at fashion week are the perfect stage to share inspiration, debut our innovations with the fashion world and elevate makeup trends in each of these countries.”
Designers, influencers, celebrities, makeup artists, beauty bloggers and editors attended all five events where Mary Kay was the official beauty partner for the spring/summer 2020 fashion week season.
“The Mary Kay Global Design Studio was created over 10 years ago to inspire beauty trends and drive innovation, fueling creativity and individuality through fashion collaborations around the world,” said Sheryl Adkins-Green, Chief Marketing Officer, and Creative & Inspiration Officer for the Mary Kay Global Design Studio. “During fashion weeks, makeup artists in collaboration with Mary Kay, unleashed some of the major trends of the season. Beauty enthusiasts can get the look ‘as seen’ on the runway or revisit the inspiration to create their own.”
Fashion Weeks Highlights:
Held in Kyiv between August 31-September 4, 2019, Ukrainian Fashion Week (UFW) kicked off the Mary Kay sponsored events in Europe. Under the artistic direction of lead makeup artist MartElle, a team of 40 beauty artists, all of whom are also members of the Mary Kay independent sales force, prepped the runway models for 30 Ukrainian designers and performed 350 different makeup looks throughout UFW. One of the fashion shows was an exclusive capsule pink bra collection collaboration between Mary Kay Ukraine and lingerie brand Keòsme aimed at supporting women diagnosed with breast cancer. Ten percent of sales proceeds from the exclusive collection will be donated to a Ukrainian nonprofit organization that promotes female health and wellness.
Bratislava Fashion Days by Mercedes-Benz was next in Bratislava on September 16-19, and Prague on October 5-6. For the second year in a row, Mary Kay Slovakia was the Official Makeup Artist for the event. Makeup artists prepared the show-stopping makeup looks worn by runway models and starred in the backstage stories on Fashion TV. Inspired by Mary Kay’s Global Beauty Ambassador Luis Casco, the “Sparkling Pewter,” “Sultry Glam,” “Sweet Champagne,” and “Garnet Gold” special looks became the highlights of the shows. The December 17 show in Bratislava marked the closing of the 2019 edition of the Fashion Days.
Mary Kay Russia has been the Official Makeup Artist of the Mercedes-Benz Fashion Week Russia (MBFW Russia) for 7 years in a row—13 consecutive seasons. The largest fashion event in Eastern Europe, MBFW Russia was held in Moscow on October 15-19. Luis Casco, and star makeup artist Andrey Shilkov, co-created the looks for 109 shows out of a total of 119, while a makeup team from the Mary Kay Russia independent sales force represented the brand backstage. The stunning beauty look imagined for the Te Amo Couture runway show was the result of the exclusive Casco-Shilkov collaboration.
The Belarus Fashion Week (BFW) held in Minsk on October 17- 20, 2019, wrapped up a successful fashion week season for Mary Kay in Eastern Europe. Mary Kay was BFW Official Makeup Artist for the 7th season in a row. A team of beauty artists from the Mary Kay Belarus independent sales force featured 650 runway looks and no less than 500 makeovers under the guidance of beauty artist maestro Alexander Kiryniuk, who also presented the season's trends.
About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company more than 55 years ago with three goals: develop rewarding opportunities for women, offer irresistible products, and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skin care, color cosmetics, and fragrances. Mary Kay is committed to empowering women and their families by partnering with organizations from around the world, focusing on supporting cancer research, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Mary Kay Ash’s original vision continues to shine—one lipstick at a time. Learn more at MaryKay.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191219005838/en/
Contact information
Mary Kay Inc. Corporate Communications
marykay.com/newsroom
972.687.5332 or media@mkcorp.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 17:00:00 EEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 16:34:00 EEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 12:00:00 EEST | Press release
Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely with healthcare authorities and other stakeholders to support timely access for people with Parkinson’s disease who continue to experience moderate to severe motor fluctuations despite current oral therapies. Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. Despite availab
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 11:16:00 EEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk28.8.2026 11:00:00 EEST | Press release
Daiichi Sankyo (TSE:4568) today announced new results from the MILOS study that demonstrate the real-world impact of bempedoic acid administered either alone or as a fixed-dose combination with ezetimibe, in the management of dyslipidaemia. Presented at the European Society of Cardiology Congress 2026 in Munich, the findings show that the clinically relevant reductions in low-density lipoprotein cholesterol (LDL-C) achieved within the first year of treatment are estimated to translate into clinically meaningful reductions in 10-year cardiovascular (CV) risk.1 The data further reinforce the clinical value of bempedoic acid, and its fixed-dose combination with ezetimibe, across a diverse range of patient subtypes, regardless of gender and glycaemic profile (diabetes, pre-diabetes, or normoglycemia).2,3 Key findings from the new analyses of the MILOS study include: 10-year CV risk estimate reduction: An analysis of 960 at-risk patients estimated that one year of bempedoic acid-add-on ther
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom